Head-to-head · WeighScore
Gala Health vs Medi-Weightloss
By GLP-1 ScorecardUpdated
Score comparison
Gala Health has the higher recorded score — 82.9/100 to 69.6/100.
Gala Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.
Before you choose
Medi-Weightloss does not publish a semaglutide price, so its Medi-Weightloss review sets out what it does disclose, while the Gala Health review explains the conditions attached to Gala Health's figure. The semaglutide cost page compares published rates across the field. Ask Medi-Weightloss for a written total before treating either one as the cheaper choice.
If neither one fits, Gala Health vs MediRX and Get Thin MD vs Medi-Weightloss compare each of them with another graded program, and the list of alternatives to Gala Health ranks the programs closest to Gala Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Gala Health | Medi-Weightloss |
|---|---|---|
| WeighScore | 82.9/100 | 69.6/100 |
| Grade | B− | C |
| Site position | #11 | #134 |
| Semaglutide | From $69/mo on the annual plan, billed once a year (campaign shows $129/mo; offers conflict—confirm billing term) | Medication-inclusive price not established; confirm clinic quote |
| Tirzepatide | From $99/mo on the annual plan, billed once a year (campaign shows $179/mo; offers conflict—confirm term) | Medication-inclusive price not established; local first-month offers vary |
| Coverage | Coverage wording differs: all 50 on homepage, most U.S. states in campaign | Clinic-specific; telehealth at participating locations |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Campaign advertises $129 semaglutide and $179 tirzepatide with medication and telehealth visits included if prescribed
- Brand-name Ozempic path and broader menopause/HRT services listed
- Terms identify clinical practice networks; actual clinician and pharmacy assignment still need checking
What to consider
- Annual-plan and no-contract campaign presentations differ; the lowest prices are advertised as billed once a year
- Cancel at least 72 hours before renewal; ordinary cancellation does not produce a refund
- Medical-disqualification refund wording differs between full-refund and remaining/current-cycle provisions
- Dispensing pharmacy not identified for an individual order; oral option is a waitlist, not a current offer
Site position #134 · C
Strengths
- Describes recurring clinic visits, nutrition guidance and body-composition reviews.
- Lists branded Wegovy, Zepbound and Saxenda alongside compounded injection options, subject to provider assessment.
- Publishes a pharmacy network; the provider chooses the dispensing assignment.
- Insurance and HSA/FSA options are described, with coverage dependent on location and plan.
What to consider
- The local $199 initial visit and $199 starting program are not a national branded-medication price.
- Medication, labs, supplements and other services can cost extra; get the complete local quote.
- Early visits can be weekly, and telehealth is not assured at every clinic.
- The selected membership, prepayment, renewal and refund agreement still needs confirmation.
Featured provider
Gala Health
Factor scores not reassessed.Gala Health scores 82.9/100 (B−). Gala offers low advertised injection prices and a branded Ozempic path, but its campaign and longer-term plan pages need to be reconciled before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.